BioMarin Pulls EU Hemophilia Gene Therapy Filing, But Is Not Giving Up

Agios’s MAA For Tibsovo also withdrawn

 
• By Neena Brizmohun

BioMarin plans to resubmit its marketing application for Roctavian to the European Medicines Agency.

Gene therapy
Several gene therapies for hemophilia are under development • Source: Shutterstock

More from Europe

More from Geography